Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
Por um escritor misterioso
Descrição
Statins improve Graves' orbitopathy in active eye disease with
PDF) The Role of Oxidative Stress and Therapeutic Potential of
Rosuvastatin in the Primary Prevention of Cardiovascular Disease
Biomedicines, Free Full-Text
PDF) Sirolimus as a second-line treatment for Graves' orbitopathy
Graves Disease: Practice Essentials, Pathophysiology, Epidemiology
Proposal for Standardization of Primary and Secondary Outcomes in
Effect of dapagliflozin on the rate of decline in kidney function
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label
de
por adulto (o preço varia de acordo com o tamanho do grupo)
